In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Eastman Kodak Co.

Latest From Eastman Kodak Co.

Kodak’s Continenza Cagey About Pharma Future

Kodak CEO Jim Continenza is revealing nothing about ongoing investigations, which leave Kodak’s plans to venture into pharmaceuticals – along with a $765m federal loan – uncertain.

Generic Drugs Legal Issues

Fujifilm Promises A Shake-Up Of Regenerative Medicines Market

Fujifilm has successfully transformed its business strategy by expanding away from traditional photographic film and toward new priority business fields – significantly in regenerative medicine. Identifying health care as a key growth area, Fujifilm targets the role of being a comprehensive provider in the fields of prevention, diagnosis and treatment.

Regenerative Medicine Regenerative Medicine

The Abbott Split Up: Who Wins?

After implementing a major workforce reduction in January, Abbott Laboratories re-organized its diversified company into three units – proprietary pharmaceuticals, durable growth products and innovation-driven devices. Its latest announcement cements that change: Abbott will divide into a diversified medical products company.

Medical Device BioPharmaceutical

Eyeon Therapeutics Inc.

The founder of Eyeon Therapeutics thinks that his firm will take giant steps forward in the next six months towards commercializing an over-the-counter nanotechnology-based eye drop for treating dry eye.

BioPharmaceutical Consumer
See All

Company Information

  • Industry
  • Diversified
  • In Vitro Diagnostics